Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2023, titled "Zydus receives final approval from the USFDA for Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL), Single-Dose Vial".